Dermatology NewsFDA approves Yuflyma as ninth adalimumab biosimilarMay 24, 2023Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
Dermatology NewsFDA approves autoinjector pen for Humira biosimilar, CyltezoMay 24, 2023PediatricsPsoriatic ArthritisRare DiseasesPsoriasis
Dermatology NewsMACE, VTE rates compared between TNF and JAK inhibitors for AxSpA and PsAMay 19, 2023Psoriatic Arthritis
Dermatology NewsBrepocitinib shows promise for psoriatic arthritis patientsMay 17, 2023Psoriatic Arthritis
Dermatology NewsAxial spondyloarthritis versus axial psoriatic arthritis: Different entities?May 9, 2023Psoriatic ArthritisPsoriasis
Dermatology NewsCOVID-19 and psoriasis: Is there a link?May 4, 2023PsoriasisInfectious DiseasesCOVID-19 UpdatesPsoriatic Arthritis
Dermatology NewsMeta-analysis examines cancer risk concern for JAK inhibitorsApril 26, 2023Psoriatic ArthritisPediatricsPsoriasis
Dermatology NewsNPF provides guidance for virtual psoriasis visitsApril 24, 2023PsoriasisMedical DermatologyBusiness of MedicinePsoriatic Arthritis
Dermatology NewsNew 46-week PsA data released for IL-17A inhibitor izokibepApril 12, 2023Psoriatic Arthritis
Dermatology NewsBiosimilars and patients: Discussions should address safety, cost, and anxiety about changeMarch 30, 2023Business of MedicinePsoriatic ArthritisPediatricsRare DiseasesPsoriasisAutoimmune Diseases
Dermatology NewsFDA approves new formulation of Hyrimoz adalimumab biosimilarMarch 27, 2023Psoriatic ArthritisPediatricsPsoriasis
Dermatology NewsNew data forecast more oral PDE4 inhibitors for psoriasisMarch 27, 2023PsoriasisAtopic DermatitisPsoriatic Arthritis
Dermatology NewsPsoriatic arthritis treatment for women falls short, study suggestsMarch 23, 2023Psoriatic Arthritis
Dermatology NewsBiologics show signs of delaying arthritis in psoriasis patientsMarch 9, 2023Psoriatic ArthritisPsoriasis
Dermatology NewsIsolated nail psoriasis may bring arthritis into playFebruary 28, 2023PsoriasisPsoriatic ArthritisHair & Nails
